Key result
After adjusting for confounding factors, women with stroke were significantly less likely than men to be treated with tissue plasminogen activator (OR 0.51; 95% CI 0.35-0.72).
Why the study?
Are gender differences in the investigation, treatment, and outcome of stroke due to confounding factors?
Cohort (n=2,725)
No
Are gender differences in the investigation, treatment, and outcome of stroke due to confounding factors?
Odds Ratio: 0.51 (95% CI 0.35–0.72)
While many gender differences in stroke care are explained by confounding factors, women remain significantly less likely to receive thrombolytic therapy even after adjustment.
No takes yet. Share an insight, caveat, or question.
May indicate persistent gender disparities in tPA use after adjustment; leaves open unmeasured confounders in this registry analysis.
Reid et al. (2008) conducted a cohort in Stroke (n=2,725). Female gender vs. Male gender was evaluated on Treatment with tissue plasminogen activator (OR 0.51, 95% CI 0.35-0.72). After adjusting for confounding factors, women with stroke were significantly less likely than men to be treated with tissue plasminogen activator (OR 0.51; 95% CI 0.35-0.72).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: